Home/Filings/4/A/0001104659-13-003957
4/A//SEC Filing

Shailubhai Kunwar 4/A

Accession 0001104659-13-003957

CIK 0001347613other

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 9:28 PM ET

Size

13.0 KB

Accession

0001104659-13-003957

Insider Transaction Report

Form 4/AAmended
Period: 2013-01-17
Shailubhai Kunwar
Chief Scientific Officer
Transactions
  • Award

    Stock Options

    2013-01-17+17,9901,010,014 total
    Exercise: $8.34Exp: 2014-04-06Common Stock (17,990 underlying)
  • Award

    Stock Options

    2013-01-17+13,4931,023,507 total
    Exercise: $8.51Exp: 2015-10-10Common Stock (13,493 underlying)
  • Award

    Stock Options

    2013-01-17+4,498992,024 total
    Exercise: $8.34From: 2003-06-13Exp: 2013-06-13Common Stock (4,498 underlying)
  • Award

    Stock Options

    2013-01-17+22,4881,045,995 total
    Exercise: $3.67Exp: 2017-04-12Common Stock (22,488 underlying)
Footnotes (4)
  • [F1]Pursuant to the Agreement and Plan of Merger, dated as of July 20, 2012, as amended October 15, 2012, by and between Synergy Pharmaceuticals Inc ("Synergy") and Callisto Pharmaceuticals, Inc. ("Callisto"), Callisto merged with and into Synergy (the "Merger"). Upon the effective time of the Merger, each share of Callisto common stock was cancelled and exchanged for .1799 shares of Synergy common stock (the "Exchange Ratio"). Each stock option exercisable for shares of Callisto common stock that is outstanding at the effective time of the Merger was assumed by Synergy and converted into a stock option to purchase the number of shares of Synergy's common stock that the holder would have received if such holder had exercised such stock option for shares of Callisto common stock prior to the Merger and exchanged such shares for Synergy common stock in accordance with the Exchange Ratio.
  • [F2]8,995 options vested on each of June 13, 2004 and December 13, 2004.
  • [F3]6,747 options vested on each of October 10, 2006 and 2007.
  • [F4]7,496 options vested on April 12, 2008, 2009 and 2010, respectively.

Documents

1 file

Issuer

SYNERGY PHARMACEUTICALS, INC.

CIK 0001347613

Entity typeother

Related Parties

1
  • filerCIK 0001307746

Filing Metadata

Form type
4/A
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 9:28 PM ET
Size
13.0 KB